{"id":"W4396590874","doi":"10.1158/1538-7445.sabcs23-gs03-03","title":"Abstract GS03-03: Ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) as adjuvant treatment in patients with HR+/HER2− early breast cancer: final invasive disease–free survival (iDFS) analysis from the NATALEE trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Aromatase inhibitor; Oncology; Breast cancer; Internal medicine; Nonsteroidal; Cancer; Adjuvant; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001657347,0.0009227325,0.001309141,0.0002724763,0.0001941093,0.0008779956,0.0006872742,0.0005954777,0.006672505],"category_scores_gemma":[0.000901872,0.0002361135,0.00191811,0.0005026608,0.0006285401,0.0004512227,0.0003893558,0.00210551,0.0011611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007821959,"about_ca_system_score_gemma":0.00131315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00101903,"about_ca_topic_score_gemma":0.004816628,"domain_scores_codex":[0.9994579,0.000331156,0.00003129173,0.00006619078,0.00004870113,0.00006469824],"domain_scores_gemma":[0.9995801,0.00007413661,0.0001006558,0.00005902839,0.0000273491,0.0001586766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9174115,0.005028661,0.005882928,0.001074387,0.00342089,0.0001135621,0.00006154417,0.001537139,0.008756939,0.0004045506,0.01034077,0.04596704],"study_design_scores_gemma":[0.8697598,0.09777941,0.01942991,0.000108894,0.002744981,0.0002978647,0.00005578445,0.001109763,0.001783783,0.0007435388,0.006145382,0.00004085596],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.968293,0.009378256,0.0007292546,0.001616983,0.0004328248,0.002030327,0.009033434,0.0002715297,0.008214269],"genre_scores_gemma":[0.9751579,0.002894875,0.001374538,0.002692463,0.0003455019,0.002061436,0.01082432,0.00005936568,0.004589726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006672505,"threshold_uncertainty_score":0.02232176,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0456993050106724,"score_gpt":0.3655562562316668,"score_spread":0.3198569512209944,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}